Reuters logo
BRIEF-Nature Cell receives FDA approval for early and mid-stage alzheimer's clinical trial
2016年11月28日 / 下午2点17分 / 1 年前

BRIEF-Nature Cell receives FDA approval for early and mid-stage alzheimer's clinical trial

Nov 28 (Reuters) - Nature Cell Co Ltd -

* Nature Cell Co Ltd receives U.S. FDA approval for phase I and II alzheimer’s clinical trial

* Announces Astrostem’s approval for phase i and phase ii clinical trials for treatment of alzheimer’s disease by U.S. FDA on November 23 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below